• Guidance
  • Interesting shortcuts
  • EFFRA Members' Perspectives
  • News Dashboard
  • Structured Wiki
    • Search
    • FoF and Made in Europe Partnership
    • Demonstrators, pilots, prototypes
    • Exploitable result(s)
    • Significant innovations and lessons learned, training aspects
    • Report - Video - Presentation - Publication....?
    • Project clusters
    • EFFRA member perspectives
    • Manufacturing future products
    • Manufacturing performance characteristics
    • Technologies and enablers
    • ICT performance characteristics
    • Standards, technical committees and working groups
    • Contribution of R&I projects to standardisation
    • Regulatory and policy aspects
    • Standards - other classifications
    • Business model aspects
    • Pathways
    • MiE SRIA R&I Priorities
    • MiE WP26-27 Consultation - Potential Research Topics only
    • MiE WP26-27 Consultation and context pointers
    • MiE WP26-27 Consultation with pointers to WP25-27 consultation
    • MiE KPIs
    • Relevant (future) calls
    • EU-Programme-Call
    • NACE code
    • EFFRA Organisations - members
    • EFFRA WG pointers
  • Pathways
    • Pathways
  • Projects
    • Projects
  • Resources
    • Resources
  • Project ideas
    • Project ideas
  • People & organisations
    • People
    • Organisations
  • portal@effra.eu
  • Visit the EFFRA website
    • Login
  • Structured Wiki
  • EU-Programme-Call
  • Horizon 2020
  • H2020-EU.3. SOCIETAL CHALLENGES
  • H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
  • H2020-EU.3.1.1. Understanding health, wellbeing and disease

H2020-EU.3.1.1. Understanding health, wellbeing and disease

  • H2020-HCO-2014
    • HCO-09-2014 ERA-NET: Systems medicine to address clinical needs
  • H2020-PHC-2014-two-stage
    • PHC-01-2014 Understanding health, ageing and disease: determinants, risk factors and pathways
  • H2020-PHC-2015-two-stage
    • PHC-02-2015 Understanding disease: systems medicine
    • PHC-03-2015 Understanding common mechanisms of diseases and their relevance in co-morbidities
  • H2020-SC1-2016-RTD
    • SC1-PM-01-2016 Multi omics for personalised therapies addressing diseases of the immune system
    • SC1-PM-04-2016 Networking and optimising the use of population and patient cohorts at EU level
  • H2020-SC1-2017-Single-Stage-RTD
    • SC1-PM-03-2017 Diagnostic characterisation of rare diseases
  • H2020-SC1-2017-Two-Stage-RTD
    • SC1-PM-02-2017 New concepts in patient stratification
  • H2020-SC1-2018-Single-Stage-RTD
    • SC1-BHC-21-2018 Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation
    • SC1-BHC-27-2018 New testing and screening methods to identify endocrine disrupting chemicals
    • SC1-HCO-04-2018 ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)
    • SC1-HCO-06-2018 Establishment of an International Network of Social Sciences Research Centres to help address governance and other challenges in the preparedness for and the response to infectious threats
  • H2020-SC1-2019-Single-Stage-RTD
    • SC1-BHC-31-2019 Pilot actions to build the foundations of a human cell atlas
  • H2020-SC1-2019-Two-Stage-RTD
    • SC1-BHC-01-2019 Understanding causative mechanisms in co- and multimorbidities combining mental and non-mental disorders
    • SC1-BHC-02-2019 Systems approaches for the discovery of combinatorial therapies for complex disorders
Powered by Chris Decubber BV